PharmaKB logo
Company Reports
Company Reports
Drug Reports
Drug Reports
Disease Reports
Disease Reports
Sets
Sets
Favorites
Favorites
Log in
Log in
AboutPricing
Company ReportsInnovation Pharmaceuticals
Innovation Pharmaceuticals
Download report
Favorite
Financial
Marketed Drugs
Clinical Trials
Financial
Stock price
No data
Company Revenue
No data
Revenue by Drug
Loading
Marketed Drugs
No data
Clinical Trials
Therapeutic Areas:
All
Classification:
All
Approval:
All
Status:
All
Phases:
All
Drug Name
Phase 1
Phase 2
Phase 3
Phase 4
Indication
Furosemide
healthy volunteers/patients
,
heart failure
,
edema
BRILACIDIN
healthy volunteers/patients
,
staphylococcal infections
,
sinusitis
,
bacterial infections
,
infectious skin diseases
,
wound infection
,
abscess
,
cellulitis
,
erysipelas
,
infections
,
communicable diseases
,
bacterial skin diseases
,
covid-19
,
head and neck neoplasms
,
stomatitis
,
mucositis
Bevifimod
healthy volunteers/patients
,
renal insufficiency
,
hepatic insufficiency
,
hepatitis c
,
chronic hepatitis c
,
hepatitis
,
hepatitis a
,
leukemia
,
b-cell chronic lymphocytic leukemia
,
t-cell lymphoma
,
hodgkin disease
,
follicular lymphoma
,
b-cell lymphoma
,
t-cell lymphoma cutaneous
,
bronchiolitis obliterans syndrome
,
glomerulonephritis
,
membranoproliferative glomerulonephritis
,
hemolytic anemia autoimmune
,
iga glomerulonephritis
,
lupus nephritis
,
amyloidosis
,
myasthenia gravis
,
immunoglobulin light-chain amyloidosis
,
paraproteinemias
,
hypophosphatasia
,
paroxysmal hemoglobinuria
Edetic acid
peripheral arterial disease
,
breast neoplasms
,
peripheral vascular diseases
,
brain neoplasms
THIOUREIDOBUTYRONITRILE
neoplasms
,
ovarian neoplasms
© 2020-2025 Collaborative Drug Discovery Inc. (CDD) | Terms of Use